Good morning. Welcome to the CONMED Corporation 2026 Annual Meeting of Stockholders. I would now like to turn the conference over to Pat Beyer. Please go ahead. Hello, and welcome to the CONMED Corporation 2026 Annual Meeting of Stockholders. I am Pat Beyer, President and CEO. It is my pleasure to welcome you here today for this meeting and to introduce LaVerne Council, Chair of the Board of Directors. Thank you, Pat. Good morning, and thank you everyone for joining us today. I'm pleased to be with all of you for our 2026 Annual Meeting of Stockholders. It is now 11:30 A.M. on May 18, 2026, and in accordance with the notice provided to all of you, the meeting is officially called to order. First, I'd like to recognize and thank my fellow members of our Board of Directors who are in attendance, Pat Beyer, David Bronson, Charles Farkas, Mark Kaye, Kim Kelderman, and Barbara Schwarzentraub. Additionally, I'd like to recognize and thank Brian Concannon, who has retired from the Board in accordance with the Director term limit policy. We extend our sincere thanks to Brian for his many years of commitment and his thoughtful leadership, particularly during his five years as Chair of the Compensation Committee. His contributions have been deeply valued by the Board and the company. We are joined here today by representatives of our Independent Auditor, PricewaterhouseCoopers. They will be available during the meeting to respond to appropriate questions. It is my pleasure to introduce CONMED's EVP Legal, General Counsel, and Corporate Secretary, Hollie Foust, who will act as Secretary of the meeting. Thank you, LaVerne. Good morning, everyone. The rules of conduct for this meeting are available on the meeting website. Notice of this meeting was furnished by the company on April 7th, 2026 to every holder of record of the company's common stock as of March 24th, 2026, the record date of this meeting. I have an affidavit from Broadridge regarding the mailing of the notice and other proxy materials as well as a certified list of stockholders, which will be filed in the corporate records for this meeting. The Board of Directors has appointed Broadridge Financial Solutions to act as Inspector of Election. Jim Raitt from Broadridge is with us today and has taken the oath of Inspector of Election earlier today, which also will be filed in the corporate records. The Inspector of Election has prepared a report stating that a quorum is present for this meeting. We are now ready to proceed with the business of the meeting. It is now 11:32 A.M. on May 18th, 2026, and the polls are now open. Any stockholder who hasn't yet voted or wishes to change their vote may do so by clicking on the voting button on the meeting website and following the instructions there using your 16-digit control number. Stockholders who have sent in proxies or otherwise voted in advance via telephone or internet and do not want to change their vote do not need to take any further action. I will introduce each of the items on the agenda and then allow for questions pertinent to the proposals. After the formal meeting has been adjourned, we will provide time for general questions. Only validated stockholders may ask questions in the designated field on the meeting website. There are three proposals before the stockholders. They are as follows. Proposal one, to elect seven Directors named in the proxy statement, each to serve on the company's Board of Directors for a one-year term until 2027's annual meeting and until a successor has been duly elected and qualified or until such earlier termination of service. The Director nominees are as follows: Pat Beyer, David Bronson, LaVerne Council, Charles Farkas, Mark Kaye, Kim Kelderman, and Barbara Schwarzentraub. Proposal two, to approve an advisory basis the compensation of the company's named executive officers disclosed pursuant to Item 402 of Regulation S-K in the compensation discussion and analysis, the summary compensation table, and the related compensation tables and narrative disclosure in the proxy statement. Proposal three, to ratify the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. As LaVerne stated earlier, we are joined today by representatives of PwC who will be available to respond to appropriate questions during the Q&A session of this meeting. You can read more information about each of these proposals in the company's proxy statement. The company has not received notice from any of its stockholders as required under its bylaws of any other matter to be considered at this meeting, and therefore, no other proposals may be properly introduced by stockholders. We will now pause for questions related to any of the three proposals. If you have a question, please submit it via the meeting website. As we have not received any questions related to the proposals, we will proceed with the meeting following a short pause for any remaining voting. Now that everyone has had the opportunity to vote, it is now 11:35 A.M., and I declare the polls for the CONMED Corporation 2026 Annual Meeting of Stockholders closed. Thank you, LaVerne. The Inspector of Election has delivered the preliminary report, and I will now provide the preliminary voting results. Each of the nominees for Directors and Proposals two and three were all approved by a majority of the votes cast. The stockholders have approved the election of seven Directors named in the proxy statement to serve on the company's Board of Directors, the advisory vote on compensation paid to our named executive officers, the ratification of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. We will be reporting the final vote results on a Form 8-K to be filed within four business days. I will now turn the podium back to LaVerne to close the official business of the meeting. Thank you, Hollie. There being no further business to come before the meeting, the CONMED Corporation 2026 Annual Meeting of Stockholders is now adjourned. I would like to turn the call back to Pat, who will lead the general Q&A session. Thank you, LaVerne. We will now address general stockholder questions other than those related to the meeting. If there are any matters of individual concern to a stockholder and not of general concern to all stockholders or if a question posed is not otherwise answered, such matters may be raised separately after the meeting by contacting our investor relations department. If you have a question and have not submitted it yet, please submit it via the meeting website. That concludes our meeting program. We thank you for your attendance and continued support. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.